Binosto Warnings and Precautions
Before starting osteoporosis treatment with Binosto, it is important to know that this drug may cause inflammation, ulcers, and bleeding in the esophagus or stomach. Warnings and precautions also extend to people with kidney disease, low blood calcium, or problems with the esophagus. In some cases, Binosto may not be an appropriate medicine for women who are pregnant or nursing.
What Should I Tell My Healthcare Provider?
You should talk with your healthcare provider prior to taking Binosto™ (alendronate effervescent tablet) if you have:
- Kidney disease, such as kidney failure (renal failure)
- A problem with your esophagus, such as narrowing of the esophagus
- Difficulty swallowing
- Low blood calcium (hypocalcemia)
- Stomach problems, such as stomach inflammation or ulcers
- Heart disease, such as heart failure
- High blood pressure (hypertension)
- Had invasive dental work, such as dental implants or extractions, or if you have plans for dental work
- Dental disease, such as gingivitis (gum disease)
- Been treated with chemotherapy or steroid medications
- A blood clotting disorder
- Dentures that do not fit well
- Been told you have problems absorbing minerals in your stomach or intestines (malabsorption syndrome)
- Been told to follow a low-salt diet
- Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Unable to stand or sit upright for at least 30 minutes
- Pregnant or thinking of becoming pregnant
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.